Skip to main content
Premium Trial:

Request an Annual Quote

Stratagene Shares Continue Slide

Shares in Stratagene fell 15 percent for the week ended Tuesday. The firm's shares led decliners in the BCW Index for the third week in a row. Since the beginning of May, Stratagene's shares have lost nearly half their value, though the reasons for the drop remain unclear (see related article).

Molecular Devices led the eight stocks that gained value during the tracking period, closing up 5.2 percent for the week. Overall, the Index gained .3 percent. In comparison, the Dow Jones Industrial Average fell .8 percent, the Nasdaq dipped .1 percent, and the Nasdaq Biotech Index gained .3 percent.

BioCommerce Week Index of Diversified Molecular Biology Tool Companies
Company
Ticker
Current Price
(June 6, 2006)
Last Price
(May 30, 2006)
% change
Agilent
A
34.04
34.08
-0.1
Applied Biosystems
ABI
30.52
29.12
4.8
Beckman
BEC
55.07
55.15
-0.1
Bio-Rad
BIO
65.31
66.83
-2.3
Bruker
BRKR
5.31
5.41
-1.8
Fisher Scientific
FSH
73.75
74.40
-0.9
GE
GE
34.55
34.05
1.5
Harvard Bio
HBIO
4.10
4.15
-1.2
Invitrogen
IVGN
64.24
64.08
0.2
Molecular Devices
MDCC
29.40
27.94
5.2
PerkinElmer
PKI
20.15
20.24
-0.4
Qiagen
QGEN
13.80
13.91
-0.8
Sigma
SIAL
69.14
68.97
0.2
Stratagene
STGN
6.08
7.16
-15.1
Thermo
TMO
36.81
36.57
0.7
Waters
WAT
43.54
41.78
4.2
BCW Index Average
36.61
36.49
0.3
The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.